Neurogenomics the neurogenomics division research programs SPAN ALL AGES, from developmental disorders early in life, through diseases of adulthood such as neuronal degeneration including ALS, alzheimer's disease and parkinson's disease as well as stroke and neurotrauma such as from concussion. Our first goal is to improve the ability to diagnose neurological disease before it strikes by understanding the individual genetic and epigenetic variation between individuals. Because these diseases impact so many lives around the world either directly (by having a disease), or indirectly (by caring for a loved one with the disease), the second goal centers on the development of new DRUG therapies that specifically utilize an individual's genetic background. Over the past 20 years, our investigators have been awarded dozens of large federal and foundation grants, and developed a research clinic focused on directly interacting with the community and patients in the AREA of precision medicine.